Eloxx Pharmaceuticals, Inc. (ELOX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-40, first reflected in a filing dated 2023-03-31; 1-for-11, first reflected in a filing dated 2026-06-01. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

12.35M
Year ended 2025-12-31
+78.6%
3-year compound annual growth
2021-12-31: 1.75M2022-12-31: 2.17M2023-12-31: 2.57M2024-12-31: 3.76M2025-12-31: 12.35M12.35M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3112.35M+228.5%2026-03-17, From 2025-01-01
2024-12-313.76M+46.2%2026-03-17, From 2024-01-01
2023-12-312.57M+18.7%2026-03-17, From 2023-01-01
2022-12-312.17M+23.9%2023-03-31, From 2022-01-01
2021-12-311.75Mn/a2023-03-31, From 2021-01-01